Treatment of indolent non-hodgkin's lymphoma with liposomal doxorubicin

被引：0
|
作者：
Ponomarova, Olga V. [1 ]
Kavetsky, R. E. [1 ]
机构：
[1] Ukrainian Acad Sci, Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [41] Rituxan delays disease progression in indolent non-Hodgkin's lymphoma
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 1472 - 1472
  • [42] A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma
    Brandt, L
    Kimby, E
    Nygren, P
    Glimelius, B
    ACTA ONCOLOGICA, 2001, 40 (2-3) : 213 - 223
  • [43] Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma
    Saven, A
    Lee, T
    Kosty, M
    Piro, L
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 2139 - 2144
  • [44] Optimizing the clinical benefit of rituximab - in indolent non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2004, 5 (03): : 149 - 151
  • [45] The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy
    Pereg, David
    Koren, Gideon
    Lishner, Michael
    HAEMATOLOGICA, 2007, 92 (09) : 1230 - 1237
  • [46] Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma
    Imrie, KR
    Linch, DC
    Czuczman, MS
    ANTI-CANCER DRUGS, 2002, 13 : S19 - S24
  • [47] First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 9 - 15
  • [48] Considerations with newer regimens for indolent non-Hodgkin lymphoma
    Rummel, Mathias
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 : S128 - S136
  • [49] Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin's lymphoma: Study of 26 patients
    Moreno, Miriam
    Sancho, Juan-Manuel
    Gardella, Santiago
    Coll, Rosa
    Garcia, Olga
    Gallardo, David
    Ribera, Josep-Maria
    MEDICINA CLINICA, 2010, 134 (02): : 72 - 75
  • [50] Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
    Nousiainen, T
    Jantunen, E
    Vanninen, E
    Remes, J
    Vuolteenaho, O
    Hartikainen, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 62 (02) : 135 - 141
12345